| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 320,456 | 297,699 | 272,688 | 388,405 | | Cost of Revenue | 265,643 | 251,962 | 244,254 | 347,352 | | | Gross Profit | 54,813 | 45,737 | 28,434 | 41,053 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,751 | 32,889 | 37,589 | 34,914 | | Non Recurring | 2,581 | 3,873 | 4,218 | 601 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,481 | 8,975 | (13,373) | 5,538 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (395) | 1,928 | 2,714 | 8,377 | | Earnings Before Interest And Taxes | 8,878 | 10,612 | (10,351) | 13,757 | | Interest Expense | 1,198 | 1,192 | 1,145 | 1,250 | | Income Before Tax | 7,680 | 9,420 | (11,496) | 12,507 | | Income Tax Expense | 1,607 | 1,971 | (982) | 4,335 | | Minority Interest | (208) | (291) | 308 | (158) | | | | Net Income From Continuing Ops | 6,073 | 7,449 | (10,514) | 8,172 | | | Non-recurring Events | | Discontinued Operations | (13,956) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,883) | 7,449 | (10,514) | 8,172 | | Preferred Stock And Other Adjustments | 40 | (14) | (13) | (13) | | | Net Income Applicable To Common Shares | ($7,843) | $7,435 | ($10,527) | $8,159 |
|
0.51% Nasdaq 
Income Statement
